Funder
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health (social science)
Reference61 articles.
1. Harvard Medical School (2007). National Comorbidity Survey (NCS) Data Table 1: Lifetime prevalence DSM-IV/WMH-CIDI disorders by sex and cohort. Retrieved October 26, 2022, from https://www.hcp.med.harvard.edu/ncs/index.php.
2. Merikangas, K. R., & McClair, V. L. (2012). Epidemiology of substance use disorders. Human Genetics, 131(6), 779–789. https://doi.org/10.1007/s00439-012-1168-0.
3. Chou, S. P., Goldstein, R. B., Smith, S. M., Huang, B., Ruan, W. J., Zhang, H., Jung, J., Saha, T. D., Pickering, R. P., & Grant, B. F. (2016). The epidemiology of DSM-5 Nicotine Use Disorder: Results from the national epidemiologic survey on Alcohol and related Conditions-III. Journal of Clinical Psychiatry, 77(10), 1404–1412. https://doi.org/10.4088/JCP.15m10114.
4. Lai, H. M. X., Cleary, M., Sitharthan, T., & Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13. https://doi.org/10.1016/j.drugalcdep.2015.05.031.
5. Khantzian, E. J. (2003). The self-medication hypothesis revisited: The dually diagnosed patient. Primary Psychiatry, 10(9), 47–54. https://doi.org/10.3109/10673229709030550.